Adjunctive benefits of low-frequency transcutaneous electrical nerve stimulation for obesity frequent chronic conditions: a systematic review

An Yu, Xiang Li, Wei Zhang, Yazhou Zhang, Xi Chen, Liuyan Wang, Mei Xie, Lei Yang
{"title":"Adjunctive benefits of low-frequency transcutaneous electrical nerve stimulation for obesity frequent chronic conditions: a systematic review","authors":"An Yu, Xiang Li, Wei Zhang, Yazhou Zhang, Xi Chen, Liuyan Wang, Mei Xie, Lei Yang","doi":"10.3389/fendo.2024.1424771","DOIUrl":null,"url":null,"abstract":"Obesity is widely recognized for its role in predisposing individuals to a spectrum of chronic health conditions. Emerging preliminary evidence points to the potential benefits of low-frequency transcutaneous electrical nerve stimulation (Lo-TENS) in enhancing various health outcomes among those with obesity and associated disorders.This systematic review was designed to assess the effectiveness of Lo-TENS for managing obesity and its related chronic diseases.For this systematic review, we included randomized controlled trials that evaluated the impact of Lo-TENS on individuals with obesity and its associated chronic diseases.Eight trials encompassing 671 participants and spanning three unique populations: essential hypertension (EH), type 2 diabetes mellitus (T2DM), and obesity were deemed eligible for inclusion in this review. Compared to baseline measurements, Lo-TENS demonstrated a tendency to positively affect blood pressure in individuals with EH and metabolic parameters in those with T2DM. Nonetheless, the efficacy of Lo-TENS in treating obesity is not yet clear when contrasted with a no-intervention control group. When compared with other intervention modalities, three of the trials reported less favorable results.Although Lo-TENS did not consistently surpass other treatments or yield substantial improvements, it generally provided greater benefits than the majority of placebo controls. This suggests that Lo-TENS could potentially serve as a beneficial adjunctive therapy in the management of obesity and its associated conditions. However, given the limited number of trials assessed, the elevated risk of bias within these studies, and the scarce evidence currently available, it is too early to reach definitive conclusions. Caution should be exercised when interpreting the current findings. There is an imperative for further high-quality research to thoroughly investigate and substantiate the efficacy of Lo-TENS in relation to obesity and its related disorders.","PeriodicalId":505784,"journal":{"name":"Frontiers in Endocrinology","volume":"64 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fendo.2024.1424771","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Obesity is widely recognized for its role in predisposing individuals to a spectrum of chronic health conditions. Emerging preliminary evidence points to the potential benefits of low-frequency transcutaneous electrical nerve stimulation (Lo-TENS) in enhancing various health outcomes among those with obesity and associated disorders.This systematic review was designed to assess the effectiveness of Lo-TENS for managing obesity and its related chronic diseases.For this systematic review, we included randomized controlled trials that evaluated the impact of Lo-TENS on individuals with obesity and its associated chronic diseases.Eight trials encompassing 671 participants and spanning three unique populations: essential hypertension (EH), type 2 diabetes mellitus (T2DM), and obesity were deemed eligible for inclusion in this review. Compared to baseline measurements, Lo-TENS demonstrated a tendency to positively affect blood pressure in individuals with EH and metabolic parameters in those with T2DM. Nonetheless, the efficacy of Lo-TENS in treating obesity is not yet clear when contrasted with a no-intervention control group. When compared with other intervention modalities, three of the trials reported less favorable results.Although Lo-TENS did not consistently surpass other treatments or yield substantial improvements, it generally provided greater benefits than the majority of placebo controls. This suggests that Lo-TENS could potentially serve as a beneficial adjunctive therapy in the management of obesity and its associated conditions. However, given the limited number of trials assessed, the elevated risk of bias within these studies, and the scarce evidence currently available, it is too early to reach definitive conclusions. Caution should be exercised when interpreting the current findings. There is an imperative for further high-quality research to thoroughly investigate and substantiate the efficacy of Lo-TENS in relation to obesity and its related disorders.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低频经皮神经电刺激对肥胖症常见慢性病的辅助疗效:系统性综述
肥胖症因其易导致一系列慢性健康问题而广为人知。新出现的初步证据表明,低频经皮神经电刺激(Lo-TENS)在改善肥胖症患者及相关疾病患者的各种健康状况方面具有潜在的益处。在本次系统性综述中,我们纳入了评估 Lo-TENS 对肥胖症及其相关慢性疾病患者的影响的随机对照试验。八项试验共有 671 名参与者,涉及三个独特的人群:原发性高血压 (EH)、2 型糖尿病 (T2DM) 和肥胖症。与基线测量值相比,Lo-TENS 显示出对 EH 患者的血压和 T2DM 患者的代谢参数产生积极影响的趋势。然而,与无干预对照组相比,Lo-TENS 在治疗肥胖症方面的疗效尚不明确。虽然 Lo-TENS 并未持续超越其他治疗方法或产生实质性改善,但它通常比大多数安慰剂对照组带来更大的益处。这表明,Lo-TENS 有可能成为治疗肥胖症及其相关疾病的一种有益的辅助疗法。然而,由于评估的试验数量有限,这些研究的偏倚风险较高,而且目前可用的证据较少,因此现在下定论还为时过早。在解释目前的研究结果时应谨慎行事。当务之急是进一步开展高质量的研究,彻底调查和证实 Lo-TENS 对肥胖及其相关疾病的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
T1 mapping combined with arterial spin labeling MRI to identify renal injury in patients with liver cirrhosis Adjunctive benefits of low-frequency transcutaneous electrical nerve stimulation for obesity frequent chronic conditions: a systematic review Cadmium activation of wild-type and constitutively active estrogen receptor alpha Editorial: Preventing cardiovascular complications of type 2 diabetes The causal relationship between antihypertensive drugs and depression: a Mendelian randomization study of drug targets
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1